But the deci­sion has cre­ated prob­lems for the researchers using the sensors.

You create a tech­nology out of neces­sity, you do good sci­ence with it, you make it widely avail­able, and when the com­pany decides to cease man­u­fac­turing, it stalls the sci­ence,” said Matthew Goodwin, an assis­tant pro­fessor at North­eastern Uni­ver­sity and founding member of Affectiva’s sci­en­tific advi­sory board.

He has hoarded 30 sen­sors to use in his ongoing studies of chil­dren with severe devel­op­mental dis­abil­i­ties, including autism. “We’re now all depen­dent on the tech­nology and there is not a good alter­na­tive in the mar­ket­place, which was the very reason we com­mer­cial­ized it in the first place.”

Read the article at The Boston Globe →